Acumen Pharmaceuticals Inc

NASDAQ:ABOS   4:00:00 PM EDT
6.32
+0.13 (+2.10%)
Earnings Announcements

Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results, Business Highlights

Published: 11/14/2022 21:47 GMT
Acumen Pharmaceuticals Inc (ABOS) - Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights.
Acumen Pharmaceuticals Inc- Cash, Cash Equivalents & Marketable Securities As of Sept.
30 Expected to Fund Clinical and Operational Goals Through 2025.
Acumen Pharmaceuticals Inc - Qtrly Loss per Share $0.26.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.